News

World Cancer Day, held 4 February each year, is a global reminder of the impact of blood cancer and the importance of better prevention, treatment and care. This year’s theme “United by Unique,” celebrates the individuality of every cancer journey while highlighting the power of collaboration and research in improving patient outcomes.

Learn more about how you can support the ALLG HSANZ Fellowship Campaign to help emerging researchers to advance blood cancer research and drive innovation through ALLG clinical trials.

The Importance of Blood Cancer Research

For the Australasian Leukaemia & Lymphoma Group (ALLG), World Cancer Day underscores the ongoing challenges in blood cancer research. Clinical trials using innovative therapies are vital to generating high-quality evidence that improves outcomes for patients. Raising cancer awareness also supports early detection, access to equitable treatment and promotes better patient care.

Clinical trials are the vital link between a discovery in the lab and a treatment reaching patients. They enable research breakthroughs and deliver Better treatments…Better lives.

Breakthroughs like the ALLG BM12 CAST trial, which is set to change 40 years of standard practice by reducing life-threatening complications of the debilitating Graft Verus Host Disease (GVHD) to improve long term patient health. Or ALLG’s AMLM26 INTERCEPT platform trial that is advancing personalised treatment approaches for acute myeloid leukaemia, offering adaptive therapies with the aim to keep patients in remission longer. These trials highlight the importance of research in ensuring innovative treatments can reach patients with blood cancer.

Investing in Future Researchers: The ALLG HSANZ Fellowship Program

The ALLG HSANZ Clinical Trials Fellowship nurtures emerging clinicians and researchers dedicated to blood cancer treatment and care. ALLG Fellows gain experience in clinical trials, receiving mentorship from scientific leaders to engage high-quality research. By investing in the best and brightest early career researchers, ALLG ensures that key discoveries continue to translate into better treatments and improved lives for people with blood cancer.

To mark World Cancer Day 2026, ALLG invited our two Fellows Dr Arina Martynchyk and Dr Safia Belbachir to share their experiences and journeys in clinical research. They spoke to the ALLG team on the opportunities and challenges for early career researchers, how their unique perspectives have shaped their research projects, and the impact their projects will have on real-world patient care. Their insights highlight the importance of collaboration, innovation and mentorship in advancing research.

Read more about the ALLG Fellowship

How you can Support Blood Cancer Research

ALLG is the only not-for-profit clinical trial research group in Australia and New Zealand committed to improving treatment and survival through leading-edge blood cancer clinical trial research.. As a not-for-profit organisation, ALLG relies on the support of our community to fund innovative trials and research programs that improve outcomes for patients.

This World Cancer Day, please support ALLG’s research through a donation to the  ALLG HSANZ Fellowship Campaign. Your support will help raise awareness of blood cancers like leukaemia, lymphoma & myeloma and the importance of clinical trials in advancing new treatments that make a real impact on people living with blood cancer.